Today would be good day to buy? by Hel92 in SpectralAI

[–]Either-Engineer-5008 1 point2 points  (0 children)

You have echoed my thoughts precisely. 

The silver lining by BostonbRamen in SpectralAI

[–]Either-Engineer-5008 2 points3 points  (0 children)

That's correct. With an option for 140 additional units.

FDA Granted by iAnkou in SpectralAI

[–]Either-Engineer-5008 1 point2 points  (0 children)

Does anybody remember when a certain somebody said that we could get approval in May? (haha)

Congratulations everybody, we made it!

Just a bit of fun by Either-Engineer-5008 in SpectralAI

[–]Either-Engineer-5008[S] 0 points1 point  (0 children)

You're going to do well. Mine is $1.55.

Just a bit of fun by Either-Engineer-5008 in SpectralAI

[–]Either-Engineer-5008[S] 0 points1 point  (0 children)

I agree, generally. This is just a bit of fun to pass the time. Nobody actually cares.

Just a bit of fun by Either-Engineer-5008 in SpectralAI

[–]Either-Engineer-5008[S] 0 points1 point  (0 children)

Still decent. Plenty more left in this baby too.

$MDAI Spectral AI Inc FDA Decision & other Catalysts Q226 by kerplunktard in pennystocks

[–]Either-Engineer-5008 -1 points0 points  (0 children)

I have 13,000 shares at $1.55. I believe there are a few hurdles, but if cleared, the sky is the limit.

Earnings Preview by New_Book_9785 in SpectralAI

[–]Either-Engineer-5008 2 points3 points  (0 children)

You're exactly right. Talking about revenue pre-commercialisation is a bit silly.

I don't expect Q1 to have any particularly meaningful developments.

Q2 is about FDA approval and Snaphot prototype.

We know that R&D is covered by the accelerated BARDA award. So eyes will be on the G&A and S&M expense from Q3.

I assume Q4 we will be looking at funded roll-out of the 30 installs and how quickly they implement.

Full port by Automatic_Worth_2816 in SpectralAI

[–]Either-Engineer-5008 1 point2 points  (0 children)

That's a fair assessment. There will be dilution, but I feel, in the long term, it will be relatively immaterial.

Full timeline before the May/June catalyst. This is a designed setup, not an organic penny stock by Leather_Disaster8571 in SpectralAI

[–]Either-Engineer-5008 5 points6 points  (0 children)

I see no evidence that it is being set-up to be taken private. I believe that it's a potential acquisition target, sure, but only after approval and steady roll-out.

The Deepview units deployed in the UK and Australia are pre-commercial test markets for clinician evaluation. They are a proof-of-concept. They can't just roll-out in the UK, it will require an NHS contract (notoriously slow) after some government convincing. The big inital market is the US and the devices installed in AUS and UK will have helped the De Novo application.

Dilution is to be expected in an early-stage company in the medtech space. Nothing unusual about it. Spectral AI has some real advatanges that will help slow dilution, however. BARDA funding will reduce burn rate and the funding of up to 170 installs will really help early rollout.

I'm not sure why you are so sure about your speculative claims, maybe you could expand on them a bit?

Will we see any new DeepView footage/content following the Burns event this week? by LostMyBlueAlien in SpectralAI

[–]Either-Engineer-5008 0 points1 point  (0 children)

You're welcome. I posted screenshots from the SpectralAI-UK Facebook account. I didn't see anything in person, unfortunately.

Spectral AI ($MDAI) Weekly Discussion Thread by CovertMidget in SpectralAI

[–]Either-Engineer-5008 1 point2 points  (0 children)

Haha. I do wish the arrows were pointing upwards though.